Processing

Please wait...

Settings

Settings

1. WO2000040970 - DETECTING AND MONITORING HIV VIRAL INFECTIONS

Publication Number WO/2000/040970
Publication Date 13.07.2000
International Application No. PCT/FR1999/003311
International Filing Date 29.12.1999
Chapter 2 Demand Filed 20.07.2000
IPC
C07K 14/16 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
08RNA viruses
15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
155Lentiviridae, e.g. human immunodeficiency virus (HIV), visna-maedi virus, equine infectious anaemia virus
16HIV-1
G01N 33/569 2006.01
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
569for microorganisms, e.g. protozoa, bacteria, viruses
CPC
C07K 14/005
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
C12N 2740/16222
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2740Reverse Transcribing RNA Viruses
00011Reverse Transcribing RNA Viruses
10011Retroviridae
16011Human Immunodeficiency Virus, HIV
16211concerning HIV gagpol
16222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
G01N 2333/161
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
2333Assays involving biological materials from specific organisms or of a specific nature
005from viruses
08RNA viruses
15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
155Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
16HIV-1, HIV-2
161gag-pol, e.g. p55, p24/25, p17/18, p.7, p6, p66/68, p51/52, p31/34, p32, p40
G01N 33/56988
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
48Biological material, e.g. blood, urine
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
569for microorganisms, e.g. protozoa, bacteria, viruses
56983Viruses
56988AIDS or HTLV
Applicants
  • INSTITUT PASTEUR DE LILLE [FR/FR]; 1, rue du Professeur Calmette Boîte postale 245 F-59019 Lille Cedex, FR (AllExceptUS)
  • CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE-CNRS [FR/FR]; 3, rue Michel Ange F-75794 Paris Cedex 16, FR (AllExceptUS)
  • GRAS-MASSE, Hélène [FR/FR]; FR (AllExceptUS)
  • TRANCHAND-BUNEL, Denis [FR/FR]; FR (UsOnly)
  • AURIAULT, Claude [FR/FR]; FR (UsOnly)
Inventors
  • TRANCHAND-BUNEL, Denis; FR
  • AURIAULT, Claude; FR
Agents
  • CABINET ORES; 6, avenue de Messine F-75008 Paris, FR
Priority Data
98/1672731.12.1998FR
Publication Language French (FR)
Filing Language French (FR)
Designated States
Title
(EN) DETECTING AND MONITORING HIV VIRAL INFECTIONS
(FR) DETECTION ET SUIVI DES INFECTIONS VIRALES A VIH
Abstract
(EN)
The invention concerns a reagent for detecting and monitoring viral infections, caused by the human immunodeficiency virus (HIV) and its uses for detecting human immunodeficiency. Said reaction comprises a mixture consisting of (1) an antigenic peptide coded by the HIV pol gene comprising 60 amino acids, preferably between 20 and 40 amino acids; and (2) a mixture (called mixotope) of convergent combinatorial peptides, derived form said antigenic peptides.
(FR)
Réactif de détection et de suivi des infections virales, provoquées par le virus de l'immunodéficience humaine (VIH) et ses applications pour la détection de l'immunodéficience humaine. Ladite réaction comprend un mélange constitué par (1) un peptide antigénique codé par le gène pol du VIH1 comprenant au plus 60 acides aminés, de préférence entre 20 et 40 acides aminés et (2) un mélange (dénommé mixotope) de peptides combinatoires convergents, dérivés dudit peptide antigénique.
Also published as
US09868399
Latest bibliographic data on file with the International Bureau